No results for ‘’
Alembic Ltd
₹89.98
(4.04%)
Sat, 27 Jun 2026, 02:24 pm
Health Technology
Pharmaceuticals: Major
24.5KAlembic Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 12.36 | 11.07 | 7.02 | 40.19 | 16.79 | 0 | 0 | 18.20 | 16 | 38.50 | 4.02 | 6.74 | 8.74 | 5.11 | 2.79 | 7.70 | 8.37 | 7.99 | 8 | 8.14 |
| Price to book ratio | 2.89 | 2.03 | 2.31 | 1.30 | 1.95 | 4.66 | 1.09 | 1.02 | 2.06 | 3.50 | 1.17 | 1.07 | 1.31 | 0.90 | 0.65 | 1.15 | 0.74 | 0.73 | 0.98 | 1.08 |
| Price to sales ratio | 1.53 | 1.12 | 0.79 | 0.39 | 0.59 | 4.88 | 1.91 | 1.21 | 3.33 | 6.94 | 7.40 | 6.98 | 11.37 | 8.82 | 12.41 | 35.94 | 23.76 | 11.97 | 13.65 | 11.40 |
| Price to cash flow ratio | 20.58 | 9.75 | 34.42 | 5.13 | 5.64 | 89.56 | 0 | 2.64 | 220.60 | 23.30 | 29.54 | 12.61 | 29.60 | 24.02 | 9.75 | 0 | 30.17 | 15.80 | 30.90 | 16.99 |
| Enterprise value | 1150Cr | 965Cr | 1192Cr | 893Cr | 1049Cr | 1042Cr | 346Cr | 233Cr | 495Cr | 910Cr | 894Cr | 872Cr | 1301Cr | 1045Cr | 804Cr | 2618Cr | 1830Cr | 1475Cr | 2144Cr | 2484Cr |
| Enterprise value to EBITDA ratio | 11.15 | 8.49 | 8.58 | 7.53 | 10.11 | 1440 | 0 | 25.50 | 28.09 | 2100 | 143.85 | 125.75 | 116.22 | 57.68 | 229.85 | 231.62 | 129.55 | 36.46 | 37.57 | 26.36 |
| Debt to equity ratio | 0.54 | 0.87 | 1.24 | 1.43 | 1.21 | 0.32 | 0.68 | 0.12 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Return on equity % | 25.75 | 19.60 | 30.89 | 3.22 | 11.83 | -4.72 | -6 | 5.70 | 13.53 | 9.76 | 43.94 | 16.96 | 16.32 | 18.58 | 25.06 | 18.46 | 9.26 | 8.34 | 12.60 | 13.73 |
Alembic Ltd Enterprise Value
The Alembic Ltd Enterprise Value is a key financial metric used by investors to evaluate Alembic Ltd's valuation, profitability, and overall financial performance. Tracking the Alembic Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Alembic Ltd (NSE: ALEMBICLTD, BSE: 506235) is currently trading at ₹89.98, with a market capitalization of ₹2408.1Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Alembic Ltd Enterprise Value is essential for fundamental analysis.
Alembic Ltd Enterprise Value Current Value
The current Alembic Ltd Enterprise Value stands at 2484Cr.
The latest Alembic Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Alembic Ltd Enterprise Value Historical Trend
The Alembic Ltd Enterprise Value has shown the following historical trend:
- 2024: 2484Cr
- 2023: 2144Cr
- 2022: 1475Cr
- 2021: 1830Cr
- 2020: 2618Cr
The recent rise in Alembic Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Alembic Ltd Enterprise Value Indicates for Investors
The Alembic Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Alembic Ltd.
Alembic Ltd Enterprise Value Analysis Summary
The Alembic Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alembic Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Alembic Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.